Cargando...
Metformin and cardiorenal outcomes in diabetes: A reappraisal
The guidance issued to the pharmaceutical industry by the US Food and Drug Administration in 2008 has led to the publication of a series of randomized, controlled cardiovascular outcomes trials with newer therapeutic classes of glucose‐lowering medications. Several of these trials, which evaluated t...
Gardado en:
| Publicado en: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Blackwell Publishing Ltd
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7317924/ https://ncbi.nlm.nih.gov/pubmed/32009286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13984 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|